Princen; Fred

Patent Applications and Registrations

Patent applications and USPTO patent grants for Princen; Fred.The latest application filed is for "pathway specific markers for diagnosing irritable bowel syndrome".

Company Profile

2.9.15

Princen; Fred - La Jolla CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pathway specific markers for diagnosing irritable bowel syndrome Grant 10,338,083 - Westin , et al.	2019-07-02
Antibodies to microbiome, stress factors and mast cell markers as diagnostic markers for IBS Grant 10,184,940 - Singh , et al. Ja	2019-01-22
Pathway Specific Markers For Diagnosing Irritable Bowel Syndrome App 20180321259 - Westin; Stefan ; et al.	2018-11-08
Pathway specific markers for diagnosing irritable bowel syndrome Grant 10,036,759 - Westin , et al. July 31, 2	2018-07-31
Pathway Specific Assays For Predicting Irritable Bowel Syndrome Diagnosis App 20180136233 - Selvaraj; Fabiyola ; et al.	2018-05-17
Pathway specific assays for predicting irritable bowel syndrome diagnosis Grant 9,891,235 - Selvaraj , et al. February 13, 2	2018-02-13
Pathway Specific Markers For Diagnosing Irritable Bowel Syndrome App 20170307637 - Westin; Stefan ; et al.	2017-10-26
Antibodies Against Serotonin, Tryptophan And Kynurenine Metabolites And Uses Thereof App 20170240652 - Selvaraj; Fabiyola ; et al.	2017-08-24
Pathway specific markers for diagnosing irritable bowel syndrome Grant 9,739,786 - Westin , et al. August 22, 2	2017-08-22
Method for determining the risk of crohn's disease-related complications Grant 9,732,385 - Barken , et al. August 15, 2	2017-08-15
Compositions and methods for detecting allelic variants Grant 9,512,482 - Princen , et al. December 6, 2	2016-12-06
Pathway Specific Markers For Diagnosing Irritable Bowel Syndrome App 20160139148 - WESTIN; STEFAN ; et al.	2016-05-19
Pathway Specific Assays For Predicting Irritable Bowel Syndrome Diagnosis App 20160130279 - SELVARAJ; FABIYOLA ; et al.	2016-05-12
Antibodies To Microbiome, Stress Factors And Mast Cell Markers As Diagnostic Markers For Ibs App 20150346200 - SINGH; SHARAT ; et al.	2015-12-03
Methods For Improving Inflammatory Bowel Disease Diagnosis App 20150072879 - Princen; Fred ; et al.	2015-03-12
Compositions And Methods For Detecting Allelic Variants App 20140248612 - Princen; Fred ; et al.	2014-09-04
Methods For Identifying Inflammatory Bowel Disease Patients With Dysplasia Or Cancer App 20140179549 - FARRAYE; FRANCIS ; et al.	2014-06-26
Methods for improving inflammatory bowel disease diagnosis Grant 8,715,943 - Princen , et al. May 6, 2	2014-05-06
Drug Selection For Malignant Cancer Therapy Using Antibody-based Arrays App 20140024548 - Singh; Sharat ; et al.	2014-01-23
Methods For Improving Inflammatory Bowel Disease Diagnosis App 20130225439 - Princen; Fred ; et al.	2013-08-29
Methods For Improving Inflammatory Bowel Disease Diagnosis App 20130203053 - Princen; Fred ; et al.	2013-08-08
Inflammatory Bowel Disease Prognostics App 20120171672 - Barken; Derren ; et al.	2012-07-05
Inflammatory Bowel Disease Prognostics App 20110045476 - Barken; Derren ; et al.	2011-02-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.